Alternatives to TG Therapeutics

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Global biopharmaceutical company focused on oncology and neuroscience treatments.

Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.

Biotechnology company focused on developing cancer immunotherapies.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing in vivo immunotherapies for autoimmune diseases and cancer.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A biotechnology company developing genetic therapies for rare disorders.

Accelerating patient access to evidence-based innovation in mental health.